Kim Raineri

Chief Technology Officer • Aspen Neuroscience

Kim has deep global experience in the cell and gene therapy industry, biologics and medical device spaces, with a distinguished track record of innovation and implementation of Good Manufacturing Practices (GMP). Prior to joining Aspen Neuroscience, Kim served as Chief Manufacturing and Technology Officer and a member of the executive team at AVROBIO, a Boston-based leader in the gene therapy space.  Before Avrobio, Kim was vice president of operations for Nikon CeLL innovation Co., Ltd, a Japanese contract development and manufacturing organization. During his tenure, he established the company as the preferred provider of custom process development and manufacturing services for cell and gene therapy products in the Japanese market. Previously, Kim held management positions at Lonza, serving as the business director for cell therapy contract manufacturing operations in Singapore for five years, and prior to that as director of operations at Lonza’s Maryland facilities. Kim was also previously the senior manager of the Tissue Processing Lab at CryoLife Inc. He holds a BS from the University of Miami and an MBA from Kennesaw State University.

Also Speaking

Luca Alberici

General Manager, Milan Facility • AGC Biologics

Alaina Schlinker

Senior Manager, Field Application Support Team • ScaleReady

Michael Conway

Senior Director, Head of Talent Acquisition and Workforce Planning • BlueRock Therapeutics

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.